Histologic, molecular, and radiologic characterization of resolving cerebral posttransplant lymphoproliferative

A F Dean1, T C Diss, A C Wotherspoon

  • 1Department of Neuropathology, Institute of Psychiatry, De Crespigny Park, London, United Kingdom.

Pediatric Research
|May 1, 1997
PubMed

Insights

Combining immunocytochemistry and PCR on minimal tissue maximizes diagnostic yield for central nervous system lymphoproliferative disorders (LPDs) in pediatric transplant patients. This approach aids in identifying LPD characteristics and guiding treatment decisions.

Area of Science:

  • Neuroscience
  • Immunology
  • Oncology

Background:

  • Lymphoproliferative disorders (LPDs) are more prevalent in pediatric immunosuppressed transplant recipients and often affect the central nervous system (CNS).
  • Biopsy justification in CNS LPDs hinges on diagnostic yield, particularly in pediatric transplant cases.

Observation:

  • A 12-year-old renal transplant patient presented with multifocal cerebral LPD, undergoing serial MRI and stereotactic biopsy.
  • The biopsy utilized immunocytochemistry and polymerase chain reaction (PCR) to analyze cellular infiltrates.
  • MRI documented signal changes during clinical recovery, noting persistent abnormalities at non-biopsied sites.

Findings:

  • Combined immunocytochemistry and PCR identified immunophenotype, lineage, clonality, viral involvement, and cellular origin in minimal biopsy tissue.
  • A novel LPD pattern revealed numerous benign T cells obscuring a small B cell clone.
  • PCR analysis confirmed the B cell clonality, indicating an underlying B cell lesion.

Implications:

  • Stereotactic biopsies combined with PCR offer maximal diagnostic information for CNS LPDs, even with limited tissue.
  • A T cell infiltrate warrants further investigation for an underlying B cell lesion.
  • Serial MRI can track LPD resolution, but residual signal abnormalities highlight the need for comprehensive diagnostic methods.

Related Concept Videos